Quantifying the relationship of HIV infection with clinicopathological spectrum and outcome among patients with colorectal cancer in a South African population
- PMID: 36407346
- PMCID: PMC9652669
- DOI: 10.4314/ahs.v22i2.4
Quantifying the relationship of HIV infection with clinicopathological spectrum and outcome among patients with colorectal cancer in a South African population
Abstract
Introduction: Literature is limited on HIV and colorectal cancer (CRC) in sub-Saharan Africa despite it being the epicentre of the HIV epidemic.
Purpose: To compare clinicopathological features and outcome of CRC in HIV-negative and HIV-positive patients.
Methods: Retrospective analysis of a prospective CRC database. Demographic details, HIV status, anatomical site, disease stage, treatment and follow-up were documented.
Results: Of 715 patients with CRC, 145 and 570 tested positive and negative respectively for HIV. Median age was 45 (IQR 36-53 and 57 (IQR 45-66) years among HIV-positive and HIV-negative patients respectively (p<0.0001). Tumour differentiation differed between the two groups (p=0.003) but staging was not different (p=0.6). Surgical resection rate was 52% for HIV-positive patients versus 59% for HIV-negative patients (p=0.07). Median follow-up was 9 (IQR 2-20.5) months for HIV-positive patients and 12 (IQR 6-29) months for HIV-negative patients (p=0.154). Recurrence rate was 14.7% among HIV positive patients and 6.8% in HIV negative patients (p=0.089).
Conclusion: When compared with HIV-negative patients, HIV-positive patients with CRC presented at a younger age and tended to have lower surgical resection rates. There was no difference between the two groups with CRC in terms of anatomical sub-site distribution, disease staging and recurrence rates.
Keywords: Colorectal cancer; HIV; Outcome; colon cancer; rectal cancer.
© 2022 Pillay SK et al.
Figures
Similar articles
-
Clinicopathological spectrum of colorectal cancer among the population of the KwaZulu-Natal Province in South Africa.Pan Afr Med J. 2020 Sep 18;37:74. doi: 10.11604/pamj.2020.37.74.21313. eCollection 2020. Pan Afr Med J. 2020. PMID: 33244337 Free PMC article.
-
Characteristics of colorectal cancer in the human immunodeficiency virus-infected African American population.Med Oncol. 2012 Sep;29(3):1773-9. doi: 10.1007/s12032-011-0015-9. Epub 2011 Jun 28. Med Oncol. 2012. PMID: 21710235
-
A South African central hospital's experience with malignant colorectal obstruction.S Afr J Surg. 2023 Jun;61(2):139-143. doi: 10.36303/SAJS.3854. S Afr J Surg. 2023. PMID: 37381812
-
Oncologic long-term outcomes of emergency versus elective resection for colorectal cancer.Int J Colorectal Dis. 2019 Dec;34(12):2091-2099. doi: 10.1007/s00384-019-03426-8. Epub 2019 Nov 11. Int J Colorectal Dis. 2019. PMID: 31709491
-
Is the clinicopathological pattern of colorectal carcinoma similar in the state and private healthcare systems of South Africa? Analysis of a Durban colorectal cancer database.Trop Doct. 2017 Oct;47(4):360-364. doi: 10.1177/0049475517710887. Epub 2017 May 24. Trop Doct. 2017. PMID: 28537520
Cited by
-
Patients with colorectal cancer combined with HIV had a worse overall survival after surgery: a meta-analysis.Front Oncol. 2025 Jan 29;15:1440105. doi: 10.3389/fonc.2025.1440105. eCollection 2025. Front Oncol. 2025. PMID: 39944832 Free PMC article.
-
Editorial.Afr Health Sci. 2022 Jun;22(2):i-vi. doi: 10.4314/ahs.v22i2.1. Afr Health Sci. 2022. PMID: 36407340 Free PMC article. No abstract available.
-
Unraveling the Complex Interconnection between Specific Inflammatory Signaling Pathways and Mechanisms Involved in HIV-Associated Colorectal Oncogenesis.Cancers (Basel). 2023 Jan 25;15(3):748. doi: 10.3390/cancers15030748. Cancers (Basel). 2023. PMID: 36765706 Free PMC article. Review.
References
-
- Suneja G, Shiels MS, Angulo R, et al. Cancer treatment disparities in HIV-infected individuals in the United States. J ClinOncol. 2014;32:2344–2350. https://dx.doi.org/10.1200%2FJCO.2013.54.8644 . - PMC - PubMed
-
- Alfa-Wali M, Tait D, Allen-Mersh T, et al. Colorectal cancer in HIV positive individuals: the immunological effects of treatment. Eur J Cancer. 2011;47:2403–2407. - PubMed
-
- Berretta M, Di Benedetto F, Bearz A, et al. FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature. Cancer Invest. 2008;26:610–614. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical